Twin Securities »

Tourmaline Bio shares owned by Twin Securities

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by Twin Securities from 13F filings

Historical chart of Twin Securities investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by Twin Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by Twin Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6M 33k 47.83

More positions owned by Twin Securities

Verona Pharma Sponsored Ads (VRNA)
Kellogg Company (K)
Merus N V (MRUS)
Mr Cooper Group
Cyberark Software SHS (CYBR)
Spirit Aerosystems Hldgs Com Cl A (SPR)
Warner Bros Discovery Com Ser A Call Option (WBD)
Surgery Partners (SGRY)
WNS HLDGS Com Shs (WNS)
Acuren Corporation (TIC)
Boeing Company Call Option (BA)
Tourmaline Bio (TRML)
Plymouth Indl Reit (PLYM)
Manchester Utd Ord Cl A (MANU)

View all positions for Twin Securities

Top funds holding Tourmaline Bio

venBio Select Advisor
QVT Financial
BlackRock
TCG Crossover Management
Pfizer
Vanguard Group
Fil
Magnetar Financial
Qiming U.S. Ventures Management
Vivaldi Asset Management
TIG Advisors
Vivo Capital
Alliancebernstein
Highland Capital Management Fund Advisors
Geode Capital Management

View all funds holding Tourmaline Bio